Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03405740Not ApplicableActive Not Recruiting

Remote Patient Management of CIEDs

Role: lead

NCT06249269Recruiting

Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

Role: lead

NCT04505007Not ApplicableCompleted

Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Long-Term Outcomes

Role: lead

NCT03636230Not ApplicableRecruiting

Remote Patient Management of CIEDs - Brady Devices

Role: lead

NCT02585817Not ApplicableCompleted

Remote Patient Management for Cardiac Implantable Electronic Devices

Role: lead

All 5 trials loaded